1. Home
  2. LUNR vs TYRA Comparison

LUNR vs TYRA Comparison

Compare LUNR & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intuitive Machines Inc.

LUNR

Intuitive Machines Inc.

HOLD

Current Price

$16.50

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$25.60

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LUNR
TYRA
Founded
2013
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LUNR
TYRA
Price
$16.50
$25.60
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$15.00
$32.17
AVG Volume (30 Days)
7.4M
603.8K
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$219,936,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$163.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.85
N/A
52 Week Low
$6.14
$6.42
52 Week High
$24.95
$25.88

Technical Indicators

Market Signals
Indicator
LUNR
TYRA
Relative Strength Index (RSI) 75.13 75.18
Support Level $10.16 $22.43
Resistance Level $12.80 $23.74
Average True Range (ATR) 1.20 1.38
MACD 0.50 0.07
Stochastic Oscillator 98.03 88.46

Price Performance

Historical Comparison
LUNR
TYRA

About LUNR Intuitive Machines Inc.

Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure. The Company operates in one operating segment and one reportable segment underpinned by three core pillars (delivery services, data transmission services, and infrastructure as a service) that have similar capabilities, customers, and economic characteristics. Revenue is from contracts with customers of orbital and lunar access services.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: